Endometriosis market expected to reach $2.5bn across 7MM by 2034 Clinical Trials Arena
Childhood traumatic events associated with endometriosis risk Clinical Trials Arena
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Clinical Trials Arena
Endometriosis linked with increased risk of autoimmune disease Clinical Trials Arena
Endometrial Cancer Treatment Market 2034: Clinical Trials, openPR.com
Botulinum toxin is being explored as a treatment for chronic pelvic pain, a major cause of suffering and disability in both women and men worldwide. For chronic pelvic pain in …
The debate around colorectal surgery for endometriosis has been ongoing, but to date no meta-analysis has investigated the impact of the different surgical approaches on the pregnancy rate. The aim …
NHS approves long-term daily pill for endometriosis in England Clinical Trials Arena
Endometriosis is an estrogen-dependent chronic inflammatory disease which causes dysmenorrhea, chronic pelvic pain, and infertility in women of childbearing age, significantly impacting their quality of life and physical and mental …
Endometriosis, a benign gynecological disorder affecting 10-15% of women during their reproductive years, is characterized by the growth of endometrial tissue outside the uterus. Despite its prevalence, the exact pathophysiology …